全崴生技股份有限公司

Company Overview

Transwell is a biotechnology firm dedicating to R&D of regenerative medicine products. Advanced cell/tissue engineering technology is employed to design and develop proprietary therapeutic or research products.
The aim is to tackle health problems that were difficult to solve before.

全崴生技股份有限公司

Major Milestones

2010

Transwell Biotech was founded and registered in Taipei, Taiwan

2012

Signed the “Licensing Agreement” with CHUV/Elanix Inc. (Switzerland)

2015

The first batch of “TWB-103” has been manufactured in the cell factory of ITRI, Taiwan

2016

Obtained IND approvals for TWB-103 from FDA, PMDA and TFDA

2017

Completed Phase I clinical trial – TWB-103 for “donor site wound”, in Taiwan

全崴生技股份有限公司 全崴生技股份有限公司